Chemicals
Build Your Comparison
Side-by-side financial analysisStock Comparison
ORGN vs GEVO vs LOOP vs CLNE vs HYLN vs JPM vs KO
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Oil & Gas Refining & Marketing
Auto - Parts
Banks - Diversified
Beverages - Non-Alcoholic
ORGN vs GEVO vs LOOP vs CLNE vs HYLN vs JPM vs KO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||||
|---|---|---|---|---|---|---|---|
| Industry | Chemicals | Chemicals - Specialty | Chemicals - Specialty | Oil & Gas Refining & Marketing | Auto - Parts | Banks - Diversified | Beverages - Non-Alcoholic |
| Market Cap | $6M | $375M | $40M | $410M | $1.44B | $908.57B | $341.71B |
| Revenue (TTM) | $14M | $174M | $514K | $439M | $6M | $280.33B | $49.28B |
| Net Income (TTM) | $-241M | $-34M | $-12M | $-99M | $-52M | $57.05B | $13.70B |
| Gross Margin | -4.4% | 47.3% | -11.9% | 16.6% | -112.7% | 60.0% | 61.7% |
| Operating Margin | -459.3% | -4.6% | -19.7% | -8.2% | -10.4% | 25.9% | 29.3% |
| Forward P/E | — | — | — | — | — | 14.6x | 24.3x |
| Total Debt | $28M | $168M | $3M | $99M | $4M | $942.38B | $45.49B |
| Cash & Equiv. | $33M | $1M | $2M | $158M | $23M | $343.34B | $10.27B |
ORGN vs GEVO vs LOOP vs CLNE vs HYLN vs JPM vs KO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 20 | Jun 26 | Return |
|---|---|---|---|
| Origin Materials, I… (ORGN) | 100 | 0.4 | -99.6% |
| Gevo, Inc. (GEVO) | 100 | 154.0 | +54.0% |
| Loop Industries, In… (LOOP) | 100 | 6.1 | -93.9% |
| Clean Energy Fuels … (CLNE) | 100 | 75.0 | -25.0% |
| Hyliion Holdings Co… (HYLN) | 100 | 16.3 | -83.7% |
| JPMorgan Chase & Co. (JPM) | 100 | 337.8 | +237.8% |
| The Coca-Cola Compa… (KO) | 100 | 160.8 | +60.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ORGN vs GEVO vs LOOP vs CLNE vs HYLN vs JPM vs KO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ORGN doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.
GEVO is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs LOOP's -95.3%
In this particular matchup, LOOP is outpaced on most metrics by others in the set.
CLNE ranks third and is worth considering specifically for sleep-well-at-night and defensive.
- Lower volatility, beta 0.48, Low D/E 17.5%, current ratio 2.32x
- Beta 0.48, current ratio 2.32x
- Beta 0.48 vs HYLN's 2.57
HYLN is the clearest fit if your priority is momentum.
- +462.5% vs ORGN's -91.8%
JPM is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 481.2% 10Y total return vs KO's 115.0%
- PEG 0.83 vs KO's 2.17
- Lower P/E (14.6x vs 24.3x), PEG 0.83 vs 2.17
KO carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 56 yrs, beta -0.23, yield 2.6%
- 27.8% margin vs LOOP's -23.9%
- 2.6% yield, 56-year raise streak, vs JPM's 1.8%, (5 stocks pay no dividend)
- 13.1% ROA vs LOOP's -100.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs LOOP's -95.3% | |
| Value | Lower P/E (14.6x vs 24.3x), PEG 0.83 vs 2.17 | |
| Quality / Margins | 27.8% margin vs LOOP's -23.9% | |
| Stability / Safety | Beta 0.48 vs HYLN's 2.57 | |
| Dividends | 2.6% yield, 56-year raise streak, vs JPM's 1.8%, (5 stocks pay no dividend) | |
| Momentum (1Y) | +462.5% vs ORGN's -91.8% | |
| Efficiency (ROA) | 13.1% ROA vs LOOP's -100.3% |
ORGN vs GEVO vs LOOP vs CLNE vs HYLN vs JPM vs KO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ORGN vs GEVO vs LOOP vs CLNE vs HYLN vs JPM vs KO — Financial Metrics
Side-by-side numbers across 7 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KO leads in 3 of 6 categories
JPM leads 1 • HYLN leads 1 • ORGN leads 0 • GEVO leads 0 • LOOP leads 0 • CLNE leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
KO leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 545394.9x LOOP's $514,000. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to LOOP's -23.9%. On growth, HYLN holds the edge at +4.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $14M | $174M | $514,000 | $439M | $6M | $280.3B | $49.3B |
| EBITDAEarnings before interest/tax | -$55M | $21M | -$10M | $11M | -$53M | $81.4B | $15.5B |
| Net IncomeAfter-tax profit | -$241M | -$34M | -$12M | -$99M | -$52M | $57.0B | $13.7B |
| Free Cash FlowCash after capex | -$59M | -$44M | -$10M | $19M | -$64M | $100.9B | $12.6B |
| Gross MarginGross profit ÷ Revenue | -4.4% | +47.3% | -11.9% | +16.6% | -112.7% | +60.0% | +61.7% |
| Operating MarginEBIT ÷ Revenue | -4.6% | -4.6% | -19.7% | -8.2% | -10.4% | +25.9% | +29.3% |
| Net MarginNet income ÷ Revenue | -17.2% | -19.4% | -23.9% | -22.7% | -8.9% | +20.4% | +27.8% |
| FCF MarginFCF ÷ Revenue | -4.3% | -25.0% | -19.9% | +4.3% | -10.9% | +36.0% | +25.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -91.2% | +47.5% | -98.4% | +12.1% | +4.8% | — | +12.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +39.3% | +2.1% | -138.7% | +90.6% | +30.0% | +16.0% | +18.2% |
Valuation Metrics
JPM leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 16.2x trailing earnings, JPM trades at a 38% valuation discount to KO's 26.1x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.92x vs KO's 2.34x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Market CapShares × price | $6M | $375M | $40M | $410M | $1.4B | $908.6B | $341.7B |
| Enterprise ValueMkt cap + debt − cash | $781,018 | $541M | $41M | $351M | $1.4B | $1.51T | $376.9B |
| Trailing P/EPrice ÷ TTM EPS | -0.02x | -11.00x | -3.19x | -1.84x | -24.55x | 16.22x | 26.12x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — | — | 14.60x | 24.27x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — | 0.92x | 2.34x |
| EV / EBITDAEnterprise value multiple | — | 83.82x | — | 74.09x | — | 18.52x | 25.45x |
| Price / SalesMarket cap ÷ Revenue | 0.32x | 2.33x | 78.12x | 0.96x | 415.67x | 3.25x | 7.13x |
| Price / BookPrice ÷ Book value/share | 0.05x | 0.76x | — | 0.73x | 7.40x | 2.51x | 9.99x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 6.84x | — | 9.01x | 64.52x |
Profitability & Efficiency
KO leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-121 for ORGN. HYLN carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs LOOP's 1/9, reflecting strong financial health.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -120.7% | -7.2% | — | -17.2% | -26.0% | +15.9% | +41.1% |
| ROA (TTM)Return on assets | -99.5% | -4.9% | -100.3% | -9.2% | -24.6% | +1.3% | +13.1% |
| ROICReturn on invested capital | -24.4% | -2.8% | — | -9.4% | -23.5% | +4.5% | +15.8% |
| ROCEReturn on capital employed | -25.7% | -3.1% | -99.2% | -9.4% | -29.4% | +8.9% | +17.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 1 | 5 | 4 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.27x | 0.36x | — | 0.18x | 0.02x | 2.60x | 1.33x |
| Net DebtTotal debt minus cash | -$5M | $166M | $679,000 | -$59M | -$19M | $599.0B | $35.2B |
| Cash & Equiv.Liquid assets | $33M | $1M | $2M | $158M | $23M | $343.3B | $10.3B |
| Total DebtShort + long-term debt | $28M | $168M | $3M | $99M | $4M | $942.4B | $45.5B |
| Interest CoverageEBIT ÷ Interest expense | -2627.81x | -0.66x | -6.22x | -0.71x | — | 0.74x | 10.70x |
Total Returns (Dividends Reinvested)
HYLN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $37 for ORGN. Over the past 12 months, HYLN leads with a +462.5% total return vs ORGN's -91.8%. The 3-year compound annual growth rate (CAGR) favors HYLN at 64.8% vs ORGN's -79.4% — a key indicator of consistent wealth creation.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -84.6% | -25.2% | -18.2% | -13.9% | +345.1% | +0.8% | +16.4% |
| 1-Year ReturnPast 12 months | -91.8% | +11.6% | -50.3% | -5.6% | +462.5% | +20.9% | +17.7% |
| 3-Year ReturnCumulative with dividends | -99.1% | +12.4% | -74.2% | -57.0% | +347.5% | +138.8% | +39.3% |
| 5-Year ReturnCumulative with dividends | -99.6% | -80.2% | -93.6% | -84.2% | -31.6% | +135.5% | +65.3% |
| 10-Year ReturnCumulative with dividends | -99.6% | -99.3% | -94.6% | -45.1% | -16.5% | +481.2% | +115.0% |
| CAGR (3Y)Annualised 3-year return | -79.4% | +4.0% | -36.3% | -24.5% | +64.8% | +33.7% | +11.7% |
Risk & Volatility
Evenly matched — JPM and KO each lead in 1 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.23 beta — it tends to amplify market swings less than HYLN's 2.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs ORGN's 3.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.54x | 1.52x | 0.74x | 0.48x | 2.57x | 0.87x | -0.23x |
| 52-Week HighHighest price in past year | $28.49 | $2.97 | $2.11 | $3.11 | $8.49 | $338.09 | $84.04 |
| 52-Week LowLowest price in past year | $0.20 | $1.12 | $0.73 | $1.75 | $1.30 | $269.72 | $65.35 |
| % of 52W HighCurrent price vs 52-week peak | +3.8% | +51.9% | +39.3% | +59.8% | +95.4% | +96.2% | +94.5% |
| RSI (14)Momentum oscillator 0–100 | 33.6 | 36.4 | 31.5 | 36.0 | 67.4 | 72.1 | 49.2 |
| Avg Volume (50D)Average daily shares traded | 563K | 3.4M | 57K | 1.2M | 3.6M | 7.4M | 13.6M |
Analyst Outlook
KO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ORGN as "Buy", GEVO as "Buy", CLNE as "Buy", HYLN as "Hold", JPM as "Buy", KO as "Buy". Consensus price targets imply 8156.9% upside for ORGN (target: $90) vs 4.5% for JPM (target: $340). For income investors, KO offers the higher dividend yield at 2.56% vs JPM's 1.83%.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | — | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $90.00 | $2.75 | — | $3.50 | $9.00 | $339.75 | $86.13 |
| # AnalystsCovering analysts | 6 | 14 | — | 22 | 6 | 61 | 48 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — | +1.8% | +2.6% |
| Dividend StreakConsecutive years of raises | 1 | — | 0 | — | — | 15 | 56 |
| Dividend / ShareAnnual DPS | — | — | — | — | — | $5.95 | $2.04 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +1.9% | 0.0% | +3.8% | +0.2% |
KO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). JPM leads in 1 (Valuation Metrics). 1 tied.
ORGN vs GEVO vs LOOP vs CLNE vs HYLN vs JPM vs KO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ORGN or GEVO or LOOP or CLNE or HYLN or JPM or KO a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -95. 3% for Loop Industries, Inc. (LOOP). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 2x trailing P/E (14. 6x forward), making it the more compelling value choice. Analysts rate Origin Materials, Inc. (ORGN) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ORGN or GEVO or LOOP or CLNE or HYLN or JPM or KO?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 2x versus The Coca-Cola Company at 26. 1x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 83x versus The Coca-Cola Company's 2. 17x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ORGN or GEVO or LOOP or CLNE or HYLN or JPM or KO?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +135. 5%, compared to -99. 6% for Origin Materials, Inc. (ORGN). Over 10 years, the gap is even starker: JPM returned +481. 2% versus ORGN's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ORGN or GEVO or LOOP or CLNE or HYLN or JPM or KO?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
23β versus Hyliion Holdings Corp. 's 2. 57β — meaning HYLN is approximately -1201% more volatile than KO relative to the S&P 500. On balance sheet safety, Hyliion Holdings Corp. (HYLN) carries a lower debt/equity ratio of 2% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — ORGN or GEVO or LOOP or CLNE or HYLN or JPM or KO?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -95. 3% for Loop Industries, Inc. (LOOP). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -188. 2% for Origin Materials, Inc.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ORGN or GEVO or LOOP or CLNE or HYLN or JPM or KO?
The Coca-Cola Company (KO) is the more profitable company, earning 27.
3% net margin versus -23. 9% for Loop Industries, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -1970. 4% for LOOP. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ORGN or GEVO or LOOP or CLNE or HYLN or JPM or KO more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 83x versus The Coca-Cola Company's 2. 17x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 6x forward P/E versus 24. 3x for The Coca-Cola Company — 9. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ORGN: 8156. 9% to $90. 00.
08Which pays a better dividend — ORGN or GEVO or LOOP or CLNE or HYLN or JPM or KO?
In this comparison, KO (2.
6% yield), JPM (1. 8% yield) pay a dividend. ORGN, GEVO, LOOP, CLNE, HYLN do not pay a meaningful dividend and should not be held primarily for income.
09Is ORGN or GEVO or LOOP or CLNE or HYLN or JPM or KO better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
23), 2. 6% yield, +115. 0% 10Y return). Hyliion Holdings Corp. (HYLN) carries a higher beta of 2. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +115. 0%, HYLN: -16. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ORGN and GEVO and LOOP and CLNE and HYLN and JPM and KO?
These companies operate in different sectors (ORGN (Basic Materials) and GEVO (Basic Materials) and LOOP (Basic Materials) and CLNE (Energy) and HYLN (Consumer Cyclical) and JPM (Financial Services) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ORGN is a small-cap quality compounder stock; GEVO is a small-cap high-growth stock; LOOP is a small-cap quality compounder stock; CLNE is a small-cap quality compounder stock; HYLN is a small-cap high-growth stock; JPM is a large-cap deep-value stock; KO is a large-cap quality compounder stock. JPM, KO pay a dividend while ORGN, GEVO, LOOP, CLNE, HYLN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.